ArticleCurrent neurovascular research2026
Gender-specific Relationship between Serum Uric Acid to Serum Creatinine Ratio and Prognosis after Cerebral Venous Sinus Thrombosis.
Article in Current neurovascular research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionSerum Uric Acid to Serum Creatinine Ratio (SUA/SCr) is a new indicator for evaluating renal function and has been found to be associated with multiple prognostic outcomes. This study explores the association between SUA/SCr and prognosis in patients with Cerebral Venous Sinus Thrombosis (CVST).
methodsRetrospectively analyze the patients with CVST admitted to the First Affiliated Hospital of Zhengzhou University from January 2011 to October 2023. The modified Rankin Scale (mRS) is used to evaluate the functional outcomes of the patients. Multivariate logistic regression analysis is adopted to assess the relationship between SUA/SCr and the functional outcomes after CVST.
resultsMale patients had higher levels of SUA and SCr than females. Multivariate logistic regression analysis showed that each 1 μ mol/L increase in SUA/SCr levels was linked to lower risks of poor prognosis (OR 0.781, 95% CI 0.621 - 0.982, P = 0.034) and mortality (OR 0.647, 95% CI 0.468 - 0.895, P = 0.009) for females. When categorized by SUA/SCr quartiles, compared with the lowest quartile of SUA/SCr, the highest and the second highest quartiles of SUA/SCr were associated with a 0.344-fold (0.107 - 1.101) and 0.837-fold (0.366 - 1.914) lower risk of poor prognosis, as well as a 0.076-fold (0.009 - 0.658) and 0.510-fold (0.192 - 1.356) lower risk of mortality in females. DISCUSSION: SUA/SCr levels may be a predictor of adverse clinical outcomes and mortality in patients with CVST, and this protective association is gender-specific.
conclusionHigher SUA/SCr levels were associated with better prognosis in females.
Indexed as
Identifiers
42003117What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.